Booz Allen Hamilton
BAH
$76.28
+0.03%
Booz Allen Hamilton is a leading global consulting firm specializing in technology solutions for defense, intelligence, and civilian government agencies, with a core focus on artificial intelligence, cybersecurity, and digital transformation. The company is a premier government contractor and a trusted advisor to the U.S. federal government, leveraging its deep domain expertise to secure and modernize critical missions. The current investor narrative centers on navigating a challenging revenue environment, as recent quarterly results show a year-over-year decline, while simultaneously positioning for long-term growth through its strategic emphasis on high-demand areas like AI and the digital battlespace amidst evolving defense budgets.…
BAH
Booz Allen Hamilton
$76.28
Related headlines
BAH 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Booz Allen Hamilton's 12-month outlook, with a consensus price target around $99.16 and implied upside of +30.0% versus the current price.
Average Target
$99.16
10 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
10
covering this stock
Price Range
$61 - $99
Analyst target range
The stock is covered by 10 analysts, and the institutional sentiment leans neutral to bearish, as evidenced by recent actions from firms like Stifel, Citigroup, and Jefferies maintaining 'Hold' or 'Neutral' ratings, while Goldman Sachs, JP Morgan, and UBS have 'Sell', 'Underweight', and 'Neutral' stances, respectively. The consensus target price and specific Buy/Hold/Sell distribution are not available in the provided data, preventing calculation of implied upside; however, the pattern of recent ratings indicates a cautious outlook with limited bullish conviction. The wide range of analyst actions, including a downgrade from TD Cowen from 'Buy' to 'Hold' in October 2025, signals heightened uncertainty and a reassessment of the company's near-term prospects, likely in response to the deteriorating revenue trend; the lack of a clear, bullish consensus and the presence of several sell-side recommendations suggest the stock faces significant headwinds before analyst sentiment improves.
Bulls vs Bears: BAH Investment Factors
The evidence currently favors the bear case, driven by the severe and ongoing revenue contraction of -10.2% YoY, which is the most concrete and damaging fundamental development. The bull case rests on a compelling valuation argument, with a PEG of 0.25 and a forward P/E near historical lows, suggesting the bad news is largely priced in. The single most important tension in the investment debate is whether the current revenue decline is a temporary, contract-driven hiccup for a defensively positioned government contractor, or the beginning of a more sustained downturn in its core markets. The resolution of this top-line trajectory will determine if the stock's deep value metrics represent a trap or an opportunity.
Bullish
- Deeply Undervalued on PEG Ratio: The stock trades at a PEG ratio of 0.25, which is exceptionally low and indicates the market is pricing in minimal growth. With a forward P/E of 12.47x, the valuation is near the lower end of its historical range, suggesting a significant margin of safety if earnings stabilize or recover.
- Robust Free Cash Flow Generation: The company generates substantial free cash flow, with TTM FCF of $933 million. This provides a strong financial cushion to service its high debt load (D/E of 4.21), fund its 2.0% dividend yield, and support share repurchases, enhancing shareholder returns even during a revenue downturn.
- Defensive Business Model with Low Beta: BAH's beta of 0.355 indicates it is significantly less volatile than the broader market, a characteristic of its defensive government contracting profile. This provides relative downside protection in turbulent markets, though it has not prevented a severe stock-specific decline.
- Strategic Focus on High-Growth Tech: The company's core focus on AI, cybersecurity, and digital transformation aligns with long-term government spending priorities, as highlighted by recent news of massive, multi-decade defense programs. This positions it for potential contract wins once the current revenue headwinds subside.
Bearish
- Severe Revenue Contraction: Recent quarterly revenue of $2.62 billion represents a 10.19% year-over-year decline and a sequential drop from $2.89 billion. This sharp deceleration indicates significant fundamental pressure, likely from contract timing or budget shifts, which is the primary driver of the stock's 34.5% annual decline.
- Profitability and Margin Compression: Gross margin contracted to 51.95% in the latest quarter from 53.63% in the prior quarter, and operating margin fell to 8.78% from 9.79%. This indicates rising cost pressures or a less favorable revenue mix, eroding profitability even as revenue falls.
- Elevated Financial Leverage: The company's debt-to-equity ratio of 4.21 is extremely high, increasing financial risk. While strong FCF provides coverage, this leverage amplifies the downside risk if the revenue decline persists and impacts cash generation.
- Persistent Technical Downtrend: The stock is down 34.5% over the past year and trades just 6.9% above its 52-week low of $73.93, entrenched in a pronounced downtrend. Momentum remains negative with a 11.4% decline over three months, showing no signs of a reversal and facing massive overhead resistance at the 52-week high of $130.91.
BAH Technical Analysis
The stock is entrenched in a pronounced and sustained downtrend, having declined 34.49% over the past year. Currently trading at $78.31, it sits just 6.9% above its 52-week low of $73.93, positioning it near the bottom of its annual range, which suggests the market is pricing in significant fundamental headwinds and presents a potential value opportunity, albeit with high risk of further weakness. Recent momentum remains negative and aligned with the longer-term downtrend, with the stock down 11.43% over the last three months and 2.56% over the past month, indicating persistent selling pressure without signs of a meaningful reversal. The stock's beta of 0.355 signals it has been significantly less volatile than the broader market (SPY), which is unusual for a growth-oriented name and may reflect its defensive government contracting profile, yet it has dramatically underperformed, evidenced by a relative strength of -63.53 versus the SPY's 29.04% gain over the past year. Key technical support is clearly defined at the 52-week low of $73.93, while resistance is far overhead at the 52-week high of $130.91; a decisive break below support could trigger another leg down, whereas a recovery would need to overcome substantial overhead supply, with the stock's low beta suggesting any potential rebound may be muted relative to market moves.
Beta
0.32
0.32x market volatility
Max Drawdown
-42.7%
Largest decline past year
52-Week Range
$74-$131
Price range past year
Annual Return
-38.2%
Cumulative gain past year
| Period | BAH Return | S&P 500 |
|---|---|---|
| 1m | -8.9% | +11.4% |
| 3m | -9.7% | +8.3% |
| 6m | -12.8% | +9.4% |
| 1y | -38.2% | +31.3% |
| ytd | -10.1% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BAH Fundamental Analysis
Revenue growth has decelerated sharply and turned negative, with the most recent quarterly revenue of $2.62 billion representing a 10.19% year-over-year decline, and a sequential drop from $2.89 billion in the prior quarter, indicating significant top-line pressure likely tied to contract timing or budget shifts. Profitability remains intact but is under strain, with net income of $200 million in the latest quarter and a net margin of 7.6%, though gross margin contracted to 51.95% from 53.63% in the prior quarter, reflecting potential cost pressures or mix shifts; operating income of $230 million yielded an operating margin of 8.78%, showing compression from the 9.79% margin in the previous quarter. The balance sheet carries elevated financial leverage with a debt-to-equity ratio of 4.21, which is high and increases financial risk, but the company maintains solid liquidity with a current ratio of 1.79 and generates robust free cash flow, with TTM FCF of $933 million providing ample capacity to service debt, fund dividends, and support share repurchases.
Quarterly Revenue
$2.6B
2025-12
Revenue YoY Growth
-0.10%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$933437000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BAH Overvalued?
Given the company's positive net income, the primary valuation metric is the P/E ratio. The trailing P/E stands at 14.29x, while the forward P/E is 12.47x; the lower forward multiple implies the market expects earnings growth, aligning with analyst EPS estimates averaging $6.93 for the coming period. Compared to industry averages, Booz Allen's valuation appears mixed; its trailing P/E of 14.29x is not directly comparable without a sector benchmark, but its Price-to-Sales ratio of 1.12x and EV/Sales of 1.11x suggest a moderate sales multiple for a consulting/services firm, with the PEG ratio of 0.25 indicating the stock is cheap relative to its growth profile if those growth expectations materialize. Historically, the stock's current trailing P/E of 14.29x is near the lower end of its own historical range observed in recent quarters, which has seen P/Es fluctuate from the low teens to over 37x; trading at this depressed level suggests the market is pricing in pessimistic expectations, potentially offering a value entry point if fundamentals stabilize.
PE
14.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -45x~111x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the company's deteriorating revenue and margin profile. The 10.2% YoY revenue decline and sequential gross margin compression from 53.63% to 51.95% create a dangerous combination that pressures earnings, which are critical for servicing its high debt-to-equity ratio of 4.21. While robust TTM FCF of $933 million provides a buffer, a prolonged revenue slump could strain this cash generation, limiting financial flexibility for dividends and buybacks. The company's dependence on large, lumpy government contracts also introduces earnings volatility and visibility risk.
Market & Competitive Risks are highlighted by the stock's dramatic underperformance (-63.5 relative strength vs. SPY) despite its low 0.355 beta, signaling severe stock-specific de-rating. Trading at a forward P/E of 12.5x near its historical lows, the primary risk is not further multiple compression but a failure of the expected earnings recovery. Competitive risks include pressure from both traditional defense contractors and non-traditional tech firms, as indicated by news of new multi-decade defense programs attracting a broader set of bidders. Regulatory and budget shifts within the U.S. federal government, its primary client, remain a constant overhang.
Worst-Case Scenario involves a continuation of the revenue decline into a sustained downturn, coupled with further margin erosion. This could trigger covenant concerns due to high leverage, force a dividend cut, and lead to a wave of analyst downgrades. The realistic downside could see the stock break its key technical support at the 52-week low of $73.93 and test levels implied by its maximum drawdown of -42.7%. From the current price of $78.31, this scenario presents a potential loss of approximately -20% to -25%, reaching the low-$70s, as the market prices in a prolonged period of no growth and elevated financial risk.